E Bardellini1, F Amadori2, R F Schumacher3, I Foresti4, A Majorana2. 1. Department Oral Medicine and Paediatric Dentistry, Dental Clinic, University of Brescia, p.le Spedali Civili n.1, 25133, Brescia, Italy. elena.bardellini@unibs.it. 2. Department Oral Medicine and Paediatric Dentistry, Dental Clinic, University of Brescia, p.le Spedali Civili n.1, 25133, Brescia, Italy. 3. Paediatric Haematology-Oncology Unit, Spedali Civili di Brescia, Brescia, Italy. 4. Microbiology Department, Spedali Civili di Brescia, Brescia, Italy.
Abstract
BACKGROUND: Oral mucositis is a common complication in pediatric cancer patients, affecting up to 80% of children. Due to neutropenia and disruption of the mucosal barrier, chemotherapy-induced oral mucositis is often complicated by super-infections. CASE REPORT: A 16-years old male with stage 3 Burkitt's lymphoma developed chemotherapy induced oral mucositis grade 3 (according to WHO scale). Ulcers were quickly growing (reaching a maximum diameter of 3 cm) and became greyish in colour, resulting in dysphagia and pain. A swab of the lesions was taken and microbiological tests were performed. The sample grew for Raoultella planticola, an encapsulated Gram-negative bacterium whose full pathogenic potential still needs to be defined. TREATMENT: The patient received antibiotic combination therapy with Amikacin and Ceftazidime for 8 days. Complete healing of the lesions and resolution of the symptoms were reached and he completed his antineoplastic therapy without further complications. FOLLOW-UP: Twelve months after the infection, he is alive and well, with no oral complaints. CONCLUSION: This is the first report of a Raoultella planticola infection in a patient with chemotherapy induced oral mucositis. This type of infection must be added to the list of organisms to be considered when caring for these patients.
BACKGROUND:Oral mucositis is a common complication in pediatric cancerpatients, affecting up to 80% of children. Due to neutropenia and disruption of the mucosal barrier, chemotherapy-induced oral mucositis is often complicated by super-infections. CASE REPORT: A 16-years old male with stage 3 Burkitt's lymphoma developed chemotherapy induced oral mucositis grade 3 (according to WHO scale). Ulcers were quickly growing (reaching a maximum diameter of 3 cm) and became greyish in colour, resulting in dysphagia and pain. A swab of the lesions was taken and microbiological tests were performed. The sample grew for Raoultella planticola, an encapsulated Gram-negative bacterium whose full pathogenic potential still needs to be defined. TREATMENT: The patient received antibiotic combination therapy with Amikacin and Ceftazidime for 8 days. Complete healing of the lesions and resolution of the symptoms were reached and he completed his antineoplastic therapy without further complications. FOLLOW-UP: Twelve months after the infection, he is alive and well, with no oral complaints. CONCLUSION: This is the first report of a Raoultella planticola infection in a patient with chemotherapy induced oral mucositis. This type of infection must be added to the list of organisms to be considered when caring for these patients.
Authors: Linda S Elting; Catherine Cooksley; Mark Chambers; Scott B Cantor; Ellen Manzullo; Edward B Rubenstein Journal: Cancer Date: 2003-10-01 Impact factor: 6.860
Authors: S Puerta-Fernandez; F Miralles-Linares; M V Sanchez-Simonet; M R Bernal-Lopez; R Gomez-Huelgas Journal: Clin Microbiol Infect Date: 2013-05 Impact factor: 8.067
Authors: Si-Hyun Kim; Kyoung Ho Roh; Young Kyung Yoon; Dong Oh Kang; Dong Woo Lee; Min Ja Kim; Jang Wook Sohn Journal: BMC Infect Dis Date: 2012-03-17 Impact factor: 3.090